摘要:
The invention concerns a monoclonal antibody directed against mammalian aurora-A kinase, the method for obtaining same, as well as its uses in cancer diagnosis and prognosis, and in pharmaceutical compositions for cancer treatment.
摘要:
The invention relates to plasmacytoid dendritic human cell lines (pDC), methods for the production thereof and to said cells. More specifically, said invention relates to the plasmacytoid dendritic human cell line called GEN2.2 which is deposited in CNCM under number CNCM I-2938. The use of said cells and pharmaceutical compounds containing plasmacytoid dendritic human cells (pDC) are also disclosed.
摘要:
The invention relates to plasmacytoid dendritic human cell lines (pDC), methods for the production thereof and to said cells. More specifically, said invention relates to the plasmacytoid dendritic human cell line called GEN2.2 which is deposited in CNCM under number CNCM I-2938. The use of said cells and pharmaceutical compounds containing plasmacytoid dendritic human cells (pDC) are also disclosed.
摘要:
A device - for performing an assay- comprising a substantially rigid support forming at least one well defining an inner cavity, having a bottom wall provided with a hole, a porous membrane sealed onto the support closing said hole and having an inner surface oriented towards the inside of the cavity and an opposite outer surface, at least one probe immobilized on the membrane, characterized in that the probe is immobilized outside the cavity and on the outer surface of the membrane.
摘要:
A device – for performing an assay-comprising a substantially rigid support forming at least one well defining an inner cavity, having a bottom wall provided with a hole, a porous membrane sealed onto the support closing said hole and having an inner surface oriented towards the inside of the cavity and an opposite outer surface, at least one probe embedded within the porous membrane so as to immobilize the probe within the membrane.
摘要:
The present invention concerns an in vitro method for determining a subject cellular humoral activity, which comprises the step of (ii) determining the expression profile of at least the CX3CR1 gene in effector cells expressing FCRG and CX3CR1, preferably CD3 - CD56 + NK cells, and (iii) comparing said expression profile to at least one control such as control values of FCRG and CX3CR1 expressing subsets in representative healthy donor control cohorts; the associated kit and the use of said kit for determining a subject cellular humoral activity directed against an antigen.
摘要:
The present invention relates to a method for inducing and amplifying specific effectors, which comprises obtaining pulsed plasmacytoid dendritic cells (pDC) by incubation of a pDC line with at least one antigen, the pulsed pDC being subsequently irradiated and brought into contact with peripheral blood mononuclear cells (PBMC), and cultured or injected into an organism. The pulsed and irradiated pDC and the PBMC share at least one major histocompatibility complex (MHC) allele.
摘要:
The invention concerns the use of deleucocytation filters for defensin purification. More precisely, the invention concerns a method for purifying defensins, including the following steps: passing a blood sample on a deleucocytation filter; detaching the cells retained on the deleucocytation filter; inducing exocytosis of the defensins by those cells.
摘要:
The invention concerns a monoclonal antibody directed against mammalian aurora-A kinase, the method for obtaining same, as well as its uses in cancer diagnosis and prognosis, and in pharmaceutical compositions for cancer treatment.